Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 1/2
This trial is looking at whether acalabrutinib can improve treatment for people with a type of non-Hodgkin lymphoma called diffuse large B cell (DLBCL).
Cancer Research UK supports this trial.
Recruitment start: 5 April 2017
Recruitment end: 2 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
University Hospital Southampton NHS Foundation Trust
Haematological Malignancies Diagnostic Service (HMDS)
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
This is Cancer Research UK trial number CRUKDE/16/006
Last reviewed: 16 January 2020
CRUK internal database number: 14311
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
